Monteris Medical Intellectual Property

Monteris Medical has invested considerable resources in creating a robust intellectual property portfolio. Our portfolio includes U.S. and foreign patents, trademarks, and copyrights, as well as trade secrets for situations in which disclosure by patent is undesirable.

In accordance with 35 U.S.C. § 287(a), the reader is hereby placed on notice of the rights of Monteris Medical in the U.S. patents that are listed on this site and associated with the specified Monteris Medical products. Further, the reader is placed on notice of the provisional rights of Monteris Medical in U.S. patent applications, which are both pending and published, and which are listed on this site. The trademarks, service marks and logos (“Trademarks”) used and displayed on this site are registered and unregistered Trademarks of Monteris Medical.

Nothing on this site should be construed as granting, by implication, estoppel, or otherwise, any license or right to use any Trademark displayed on the site, without the written permission of the Trademark owner. Monteris Medical aggressively enforces its intellectual property rights to the fullest extent of the law.

Our Patented Devices

NeuroBlate® System
US 6,418,337
US 7,167,741
US 7,344,529
US 7,691,100
US 8,256,430
US 2013/0006230

AtamA™ Patient Board

Laser Probe
US 6,418,337
US 7,344,529

Probe Driver
US 2010/0042112

AXiiiS® Miniframe
US 2010/0042111